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1. In~~uction 
The involvement of cyclic AMP in the control of 
acid secretion by gastric mucosa has been suggested 
[l-3] . One experimental line of evidence has con- 
cerned the stim~atory action of methyl xanthines 
which are known to inhibit cyclic AMP-phosphodies-. 
terase. This enzyme, which converts cyclic AMP to 
5’-AMP, is the only known enzymatic regulator of 
cyclic AMP catabolism 141. Thus the extent and dur- 
ation of any cellular effect mediated by cyclic AMP 
will be controlled by the activity of the phosphodies- 
terase. The import~ce of this enzyme has been real- 
ized in recent years, and has been documented by a 
number of publications [5-121. Cheung [6] and 
others [7,8] have demonstrated a heat-stable, non- 
dialysable “active factor” from brain and liver tissues. 
Such findings uggest that the activator might be 
playing a fundamental role in regulating the phospho- 
diesterase in vivo. 
In the present paper we demonstrate a heat-stable 
dialysable “activator” and a heat-stable nondialysable 
“inhibitor” of the cyclic AMP-phosphodiesterase c- 
tivity obtained from the oxyntic, or acid-secreting, 
cells of bullfrog gastric mucosa. 
2. Materials and methods 
The oxyntic cells from bullfrog gastric mucosa were 
collected by a slight modi~cation of the method re- 
ported earlier [ 131. Details of this procedure will be 
published elsewhere [ 141. 
The oxyntic cells were homogenized in either 2.0 
mM acetate buffer pH 6.8 or 0.25 M sucrose, adjusted 
aorta-Holland ~blishing Company - Amsterdam 
to pH 7.3 with Tris. The phosphodiesterase was pre- 
pared by (NIi,), SO, fractionation of the lOO,O~ 
g supematant. All operations were run at O-4”. The 
supernatant was first saturated with (NH,), SO4 to 
16% (w/v), centrifuged at 15,000 g for 10 min and 
the precipitate discarded. The supernatant fraction 
was then brought up to 34% saturation with (NH,), 
SO4. After centrifugation at 15,000 g, the pellet 
contained about 85-90% of the total cyclic AMP 
phosphodiesterase ctivity. This pellet was resuspended 
in 0.05 M Tris buffer, pH 8.0 containing 0.1% p-mer- 
captoethanol and stored between 04” for use as the 
enzyme source. For preparation of the dialysable 
“active factor” the pellet was dissolved in glass dis- 
tilled water containing 0.1% l.I-mercaptoethanol and 
the pH adjusted to 8.0 by adding Tris. 
The heat-stable, dialysable “active factor” was 
prepared in the following 2 ways: 1) The enzyme 
preparation (ca. 5 mg protein/ml) was heat inactivated 
at 85” for 5 min. Denatured protein was removed by 
centrifugation and the supernatant was dialyzed 
against glass distilled water overnight in the cold. 
The dialysate was lyop~~zed and dissolved in a vol- 
ume equal to that of the original solution. 2) With- 
out denaturation the enzyme solution was dialyzed 
overnight against cold glass distilled water containing 
0.1% ~-mercapt~thanol. The dialysate was lyophil- 
ized and redissolved ina volume of glass distilled 
water equal to that of the original solution. A portion 
was assayed after one month (aged dialysate). 
The material retained in the dialysis bag after 
dialysis of the heat inactivated supernatant was the 
source of the heat-stable, nondialysable “inhibitor 
factor”. 
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Table 1 Table 2 
Effect of Mg’+, theophylline and the supernatant 
of the heat inactivated (85” for 5 min) enzyme solution on 
the dialysed and nondialysed cyclic AMP phosphodiesterase. 
Effect of “inhibitor factor”, “activator factor” 
and theophylline on phosphodiesterase activity 
of dialyzed enzyme preparation. 
Fraction Activity 
(nmole/mg 
protein/l0 mm) 
Fractions 
1. Nondialysed enzyme (without Mggz+) 10.0 
2. Nondialysed enzyme 94.0 
3. Nondialysed + 85”, 5 min supernatant 90.0 
4. Nondialysed + theophylline 61.3 
5. Dialysed enzyme (without Mg*+) 0.0 
6. Dialysed enzyme 35.0 
7. Dialysed + 85”, 5 min supernatant 80.0 
8. Dialysed + supernatant + theophyllme 41.6 
9. Dialysed + theophylline 31.0 
10. 85”, 5 min supernatant 0.0 
1. Dialyzed enzyme 
2. Dialyzed enzyme + inhibitor 
3. Dialyzed enzyme + activator 
4. Dialyzed enzyme + inhibitor 
+ activator 85.2 
5.4 + theophylline 65.6 
6. 3 + theophylline 82.0 
Each result represents average values from 3 different pre- 
parations. Details of the experimental and assay conditions 
are given in Materials and methods. Theophyllme was used 
at a final concentration of 10 mM. For the dialysed enzyme 
preparation, the enzyme solution was dialysed at 4” over- 
night against 0.05 M Tris-Cl pH 8.0 containing 0.1% pmer- 
captoethanol and 1.0 mM EDTA. 500-700 pg of the 
enzyme protein was used for each assay. 0.1 ml of the 85”, 
5 mm supernatant was used. 
Each result represents average values from 4 different pre- 
parations. Preparation of the “inhibitor” and “activator” 
fractions have been described in Materials and methods. 
0.1 ml of the “activator” and “inhibitor” were used. 500- 
700 pg of enzyme protein was used for each assay. 
The activity of cyclic AMP phosphodiesterase was 
assayed using 3 H-cyclic AMP (Schwarz Radiochemi- 
cals) as substrate. Advantage was taken of the fact 
that oxyntic cells contain virtually no S’nucleotidase 
activity [ 121. The reaction mixture contained, in a 
total volume of 0.5 ml, 1 .O pmole cyclic AMP, 5 .O 
nmole Tris pH 9.0,2.5 pmole MgC12 and necessary 
amounts of enzyme and other test substances. The 
reaction was carried out for 10 min at 37”) stopped 
in a boiling water bath for 3 min, centrifuged and 
then 0.1 ml of the supernatant was used for chroma- 
tographic assay. 5’-AMP formed in the reaction was 
separated by paper chromatography using isopropanol: 
NH3 :H20 (7:2:1) solvent system. The 5’-AMP spots 
were detected under W, cut out and then counted in 
“Aquasol” scintillation fluid (New England Nuclear). 
and theophylline on the enzyme activity. Dialysis of 
the enzyme caused more than 50% reduction of the 
activity which can be almost fully restored by adding 
back the 85”, 5 min supematant. Theophylline 
(10 mM) can only inhibit 30-50% of the total ac- 
tivity both from the nondialysed enzyme preparation 
as well as dialysed reconstituted enzyme preparation. 
It is noteworthy that theophylline has practically no 
effect on the activity of the dialysed enzyme pre- 
paration. This experiment shows that the 85”, 5 min 
supernatant contains some heat-stable factor(s) which 
can restore to a great extent the activity of the dia- 
lyzed enzyme. This also indicates that theophylline 
can only prevent the stimulation caused by the 85”, 
5 min supernatant fraction but has no effect on the 
activity of the dialysed enzyme (basal activity). 
3. Results and discussion 
Table 1 compares the phosphodiesterase activity 
of the nondialyzed and dialyzed enzyme preparations 
and the effects of Mg*+, heat inactivated supernatant 
Dialysis of the 85”, 5 min supematant produced 
interesting fractions in both the dialysable and non- 
dialysable portions of the material as shown in table 
2. The dialysable material produced a marked stimul- 
atory effect on phosphodiesterase activity (about 
2-3 fold) and we refer to this fraction as “activator”. 
On the other hand we refer to the nondialysable 
fraction as “inhibitor” since it was effective in abol- 
ishing the stimulation produced by the dialysable 
active factor. However, the “inhibitor” fraction had 
no effect when added to the dialysed enzyme alone. 
The combined effect of the dialysable and the non- 
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Fig. 1. Stimulation of cyclic AMP phosphodiesterase activity 
by different amounts of “active factor” prepared from the 
85”) 5 mm supernatant. The fraction collected by saturation 
with 34% (NH4fsS04 was dialyzed overnight and used as 
the enzyme source. The methods for preparation of dialyzed 
enzyme and activator are described in Materials and methods. 
500 erg of enzyme protein was used for each assay. 
dialysable factors is like that of the total 85”, 5 min 
supernatant. But in the absence of the “inhibitor fac- 
tor”, the stimulation caused by the dialysable “active 
factor” is somewhat more than that caused by the 
85”, 5 min supematant. These observations clearly 
demonstrate the presence of 2 distinct factors, one 
acting as an “inhibitor” and the other acting as an 
“activator” of the phosphodiesterase nzyme. In 
the absence of the “activator” and “inhibitor” 
factors, theophylline seems to be a relatively poor 
inhibitor of phosphodiesterase activity, Thus there 
appears to be a complex interplay between inhibitor, 
activator and theophylline in the regulation of phos- 
phodiesterase activity. 
Fig. 1 shows the dose-de~ndent activation of the 
phosphodiesterase by the “active factor” fraction 
from the heated supematant. The nature of the 
curve indicates a stoichiometric relation between the 
two. 
We have also obtained an active factor by dialys- 
ing the enzyme preparation ~thout the heat inactiv- 
ation process. The dialysable fraction from this pro- 
cedure is also active in stimulating phosphodiesterase 
as shown in table 3. Apparent differences in activation 
Table 3 
Comparison of fresh and aged dialysates 
of the enzyme solution on phosphodiesterase activity. 
Fraction Activity 
(nmole/mg 
protein/ 10 min) 
1. Dialyzed enzyme 
2. Dialyzed enzyme + fresh dialysate 
(active factor) 
3. Dialyzed enzyme + aged dialysate 
(aged active factor) 
35.0 
86.6 
35.6 
Each result represents average values from 3 different pre- 
parations. Details of the preparation of “fresh” and “aged” 
factors are described in Materials and methods. 0.1 ml of 
fresh and aged preparations of the “active factor” was used. 
500-700 I.cg of enzyme protein was used for each assay. 
by fractions prepared by the 2 methods may be due 
to differences in yield (c.f. table 2 and 3). On stand- 
ing at O-4” for a period of 1 month, the “active 
factor” completely lost its activity. 
The nature of the “active factor” and the cause 
for its deterioration with time are still not clear. 
However, we have performed some preliminary ex- 
periments directed toward characterization of the 
material. Pronase digestion for as long as 30 hr does 
not inactivate the “active factor”, indicating that 
the material is not a poly~ptide nor is its activity 
related to conjugation to some dialysable polypep 
tide. 
Spectral analysis of the dialysable active material 
prepared by either of the 2 methods revealed ab- 
sorption maxima at 207 and 244 with a shoulder 
at 282 nm. Interestin~y, when the “active factor” 
prepared by the latter method was inactivated after 
long term storage the spectral properties were some- 
what altered: the shoulder, initially at 282, shifted 
to 292 nm, while the other peaks remained unchanged. 
Furthermore, when the inactivated factor was chroma- 
tographed in the isopropanol: NH, : Hz 0 system a UV 
absorbable material was detected with an Rf value of 
about 0.95. After eluting the spot in 0.05 M phos- 
phate buffer pH 7.4 the UV spectra revealed a peak 
of 207 nm with a shoulder at 244 nm. Chromato- 
graphy of the fresh, active material did not reveal 
such a spot. 
Although the results presented in this paper do 
not elucidate the mechanism of action of the “inhibi- 
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tor” and “activator” factors on cyclic AMP phospho- 
diesterase activity, the possibility is suggested that 
these factors might be playing an important role in 
the regulation of the phosphodiesterase in viva in 
bullfrog gastric mucosa. Consequent alterations in 
tissue level of cyclic AMP would have profound 
effects on secretory activity. Furthermore, it would 
be of interest to determine whether such regulating 
factors are more general for cyclic AMP phosphodies- 
terase activity in other systems. 
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